NCT07427186
- Conditions
- Solid Cancers
- Locations
-
- Institut Universitaire Du Cancer de Toulouse - Oncopole Toulouse, France
- Chu Rangueil Toulouse, France
- Hopital Larrey Toulouse, France
Clinical trial condition
Solid Cancers
Explore clinical trials studying Solid Cancers. Study availability and eligibility vary by location and protocol.
39 public trials
11 recruiting studies
Solid Cancers trial results
NCT07675967
- Conditions
- Adenocarcinoma Of Esophagus, Bone Diseases, Bone Diseases, Developmental, +54 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Conditions
- Anxiety Depression, Anxiety Disorders, Behavior, +6 more
- Locations
-
- Sultan Qaboos Comprehensive Cancer Care and Research Center - University Medical City Muscat, Seeb, Oman
NCT03514368
- Conditions
- Solid Cancers
- Locations
-
- Hopital Larrey Toulouse, France
- Institut Universitaire Du Cancer de Toulouse - Oncopole Toulouse, France
- Chu Rangueil Toulouse, France
Recruiting
xDRIVE for Florida-based Cancer Patients
NCT07167381
- Conditions
- Cancer, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- First Ascent Biomedical Miami, Florida, United States
- Florida International University Miami, Florida, United States
Recruiting
Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors
NCT07058948
- Conditions
- Immune Checkpoint Inhibitor, Lung Cancer, Lung Diseases, +8 more
- Locations
-
- Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine Cangzhou, Hebei, China
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
NCT07479667
- Conditions
- Adjuvant Therapy, Solid Cancers
- Locations
-
- Shanghai Mengchao Tumor Hospital Shanghai, China
NCT07371663
- Conditions
- Ataxia, Ataxia Telangiectasia, Brain Diseases, +60 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Henan Cancer Hospital Zhengzhou, Henan, China
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
Recruiting
Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
NCT07170293
- Conditions
- Solid Cancers
- Locations
-
- Tianjin Medical Unversity Second Hospital Tianjin, Tianjin Municipality, China
NCT06883539
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +31 more
- Locations
-
- China Medical University Hospital Taichung, Taiwan
- National Cheng Kung University Hospital Tainan, Taiwan